MCK vs CVS vs BTSG Stock Comparison

Mckesson, Cvs Health and BrightSpring Health Services Prices as of Nov 13, 2026 Peers: Industry group
MCK Mckesson Corp
$1,102.82 +12.7% 1M +30.3% 1Y
Market cap
$127.33B
P/E
27.3x
Revenue (TTM)
$418.79B
Div. yield
0.31%
Drug Distribution Healthcare
5 wins
CVS CVS HEALTH Corp
$89.33 -1.2% 1M +12.7% 1Y
Market cap
$114.34B
P/E
10.4x
Revenue (TTM)
$420.61B
Div. yield
2.99%
Managed Care Healthcare
4 wins

Head to Head

12 decided of 12

Mckesson leads on 5 of the 12 questions below (Mckesson 5, Cvs Health 4, BrightSpring Health Services 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionMCKCVSBTSGLeader
Larger companyMarket capitalisation $127.33B $114.34B $14.16B MCK
Cheaper on earningsLower P/E, profitable companies only 27.3x 10.4x 35.9x CVS
Cheaper on forward earningsLower price / next fiscal year consensus EPS 22.8x 10.2x 38.9x CVS
Faster revenue growthRevenue growth, trailing twelve months +8.2% +6.7% +26.0% BTSG
More profitableNet margin, trailing twelve months 1.1% 2.6% 2.7% BTSG
Better return on capitalReturn on invested capital 98.7% 9.7% 10.0% MCK
Less leveragedLower net debt / EBITDA 0.4x 2.3x 2.1x MCK
Higher dividend yieldTrailing dividend yield 0.31% 2.99% — CVS
Better 1-year returnPrice return, last 12 months +30.3% +12.7% +124.3% BTSG
Better 5-year returnAnnualised price return, 5 years +37.5%/yr -1.0%/yr — MCK
Less volatileAnnualised volatility, 1 year 31.4% 35.1% 45.8% MCK
Higher overall scoreMean of the five percentile scores vs peers 58/100 72/100 65/100 CVS

Percentile Scorecard

MCKCVSBTSG

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisMCKCVSBTSG
Valuation 65 #10 of 27 100 #1 of 27 57 #43 of 99
Growth 56 #12 of 26 80 #6 of 26 93 #7 of 89
Profitability 56 #12 of 26 84 #5 of 26 64 #34 of 92
Financial Health 56 #12 of 26 24 #20 of 26 47 #55 of 103
Shareholder Returns 59 #8 of 18 71 #6 of 18 66 #22 of 63
Overall 58 72 65
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • CVS ranked among 27 companies in Healthcare Payers and Distributors
  • BTSG ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodMCKCVSBTSGSPY
1 month +12.7%-1.2%+12.4% -2.0%
3 months +26.9%-8.1%+15.4% -2.8%
6 months +45.0%-6.8%+23.0% +2.0%
Year to date +34.4%+12.6%+90.1% +10.6%
1 year +30.3%+12.7%+124.3% +12.2%
3 years +143.0%+30.4%— +68.1%
3 years, per year +34.5%+9.3%— +18.9%
5 years +390.5%-5.0%— +61.4%
5 years, per year +37.5%-1.0%— +10.1%
10 years +671.0%+19.0%— +248.5%
10 years, per year +22.7%+1.8%— +13.3%

Risk

MeasureMCKCVSBTSGSPY
Volatility, 1Y 31.4%35.1%45.8% 13.6%
Downside volatility, 1Y 27.2%38.8%50.7% 13.9%
Beta vs S&P 500, 1Y -0.18-0.051.08 1.00
Return / volatility, 1Y 0.970.362.71 0.90
Max drawdown, 5Y -27.2%-60.5%-35.6% -25.4%
From 52-week high 0.0%-19.2%-2.3% -3.2%
52-week high $1,102.82$110.55$72.91 $779.14
52-week low $725.17$70.08$31.36 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleMCKCVSBTSG
P/E now vs peer median 27.3xmedian 25.2x 10.4xmedian 25.2x 35.9xmedian 22.4x
P/S now vs peer median 0.3xmedian 0.4x 0.3xmedian 0.4x 0.9xmedian 1.3x
EV/EBITDA now vs peer median 17.4xmedian 14.5x 8.2xmedian 14.5x 22.6xmedian 14.2x
P/FCF now vs peer median 17.9xmedian 16.5x 7.3xmedian 16.5x 28.8xmedian 19.0x
P/B now vs peer median -32.2xmedian 2.7x 1.4xmedian 2.7x 6.5xmedian 2.6x
PEG now vs peer median 1.72median 1.72 1.22median 1.72 —median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsMCKCVSBTSG
Revenue $418.79B $420.61B $15.25B
Gross profit $15.37B $186.06B $1.91B
Operating income $6.69B $15.06B $520.43M
Net income $5.43B $11.09B $410.46M
Free cash flow $7.11B $15.57B $492.41M
EPS (diluted) $40.27 $8.55 $1.86
Cash & equivalents $6.53B $11.74B $717.84M
Total debt $9.21B $60.68B $2.18B
Shares (diluted) 116.70M 1.29B 220.23M
Enterprise value $111.26B $63.29B $11.04B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricMCKCVSBTSG
P/E 27.3x 10.4x 35.9x
P/FCF 17.9x 7.3x 28.8x
P/Operating cash flow 17.0x 6.1x 23.5x
P/S 0.3x 0.3x 0.9x
P/B -32.2x 1.4x 6.5x
P/Tangible book -16.1x 2.0x 8.4x
EV/EBITDA 17.4x 8.2x 22.6x
EV/EBIT 19.4x 10.6x 30.0x
EV/Revenue 0.3x 0.4x 1.0x
EV/FCF 18.3x 10.3x 31.7x
EV/Operating cash flow 17.3x 8.6x 25.9x
PEG (3Y EPS CAGR) 1.72 1.22 –

Growth

14 metrics
MetricMCKCVSBTSG
Revenue growth (1Y) 8.2% 6.7% 26.0%
Revenue CAGR (3Y) 12.9% 6.5% –
Gross profit growth (1Y) 11.8% 5.3% 32.0%
Gross profit CAGR (3Y) 7.6% 10.9% –
Operating income growth (1Y) 27.3% 206.4% 114.5%
Operating income CAGR (3Y) 16.1% 2.4% –
Net income growth (1Y) 28.5% 2,369% 219.3%
Net income CAGR (3Y) 14.2% 8.6% –
EPS growth (1Y) 24.2% 2,213% 213.4%
EPS CAGR (3Y) 15.9% 8.5% –
Operating cash flow growth (1Y) 9.3% 105.4% 72.6%
Operating cash flow CAGR (3Y) 15.2% 9.9% –
Free cash flow growth (1Y) 11.8% 147.4% 78.3%
Free cash flow CAGR (3Y) 16.3% 11.3% –

Profitability

14 metrics
MetricMCKCVSBTSG
Gross margin 3.7% 44.2% 12.5%
EBITDA margin 1.8% 4.7% 4.5%
Operating margin 1.6% 3.6% 3.4%
Pretax margin 1.6% 2.9% 2.5%
Net margin 1.1% 2.6% 2.7%
FCF margin 1.7% 3.7% 3.2%
Operating cash flow margin 1.8% 4.4% 4.0%
Return on equity – 13.8% 19.4%
Return on assets 6.0% 4.3% 6.7%
Return on invested capital 98.7% 9.7% 10.0%
Return on capital employed 42.0% 9.2% 11.8%
Asset turnover 4.6x 1.6x 2.5x
Cash conversion (OCF / net income) 1.4x 1.7x 1.5x
Stock comp / revenue – 0.2% 0.4%

Financial Health

11 metrics
MetricMCKCVSBTSG
Debt / assets 10.0% 23.5% 34.8%
Debt / equity -2.3x 0.8x 1.0x
Net debt / EBITDA 0.4x 2.3x 2.1x
Debt / FCF 1.3x 3.9x 4.4x
Liabilities / assets 104.3% 68.7% 65.3%
Equity / assets -4.3% 31.3% 34.7%
Interest coverage 21.9x 4.9x 3.6x
Current ratio 0.9x 0.9x 1.6x
Quick ratio 0.5x 0.8x 1.2x
Cash ratio 0.1x 0.2x 0.4x
Altman Z-score 5.83 2.51 5.02

Shareholder Returns

7 metrics
MetricMCKCVSBTSG
Dividend yield 0.3% 3.0% –
Net buyback yield 5.2% -0.4% 0.5%
Shareholder yield 5.6% 2.6% 0.5%
Payout ratio (earnings) 7.4% – –
Payout ratio (FCF) 5.6% – –
Dividend growth (1Y) 10.5% – –
Dividend CAGR (3Y) 9.8% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusMCKCVSBTSG
Forward P/E 22.8xFY2026 10.2xFY2026 38.9xFY2026
EPS, next fiscal year $48.34FY2026 $8.80FY2026 $1.83FY2026
EPS growth, next FY +23.6%FY2026 +30.4%FY2026 +83.0%FY2026
EPS growth, the year after +11.9% +1.1% +43.7%
Revenue, next fiscal year $447.65BFY2026 $431.16BFY2026 $16.69BFY2026
Revenue growth, next FY +11.0%FY2026 +7.2%FY2026 +29.3%FY2026
Revenue growth, the year after +1.5% -5.3% +3.1%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersMCKCVSBTSG
Held by institutions 89.1% 89.1% 100.0%
Institutions holding 2,014 2,074 423
Change in shares held, QoQ -0.7% +3.5% -0.7%
Institutions buying 883 1,103 309
Institutions selling 793 733 83
Buyers to sellers 1.11 1.50 3.72

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

MCKCVSBTSG
MCK 1.00 0.02 0.09
CVS 0.02 1.00 0.19
BTSG 0.09 0.19 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, MCK, CVS and BTSG?

Mckesson (MCK) is the largest by market capitalisation: Mckesson (MCK) $127.33B, Cvs Health (CVS) $114.34B, BrightSpring Health Services (BTSG) $14.16B.

Which stock is cheaper, MCK, CVS and BTSG?

Cvs Health (CVS) trades on the lowest price-to-earnings ratio (Mckesson (MCK) 27.3x, Cvs Health (CVS) 10.4x, BrightSpring Health Services (BTSG) 35.9x). On next year's consensus earnings, Cvs Health (CVS) is cheapest (Mckesson (MCK) 22.8x, Cvs Health (CVS) 10.2x, BrightSpring Health Services (BTSG) 38.9x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

BrightSpring Health Services (BTSG) grew revenue fastest over the trailing twelve months: Mckesson (MCK) +8.2%, Cvs Health (CVS) +6.7%, BrightSpring Health Services (BTSG) +26.0%.

Which company is more profitable?

BrightSpring Health Services (BTSG) has the highest net margin (Mckesson (MCK) 1.1%, Cvs Health (CVS) 2.6%, BrightSpring Health Services (BTSG) 2.7%). On return on invested capital, Mckesson (MCK) leads (Mckesson (MCK) 98.7%, Cvs Health (CVS) 9.7%, BrightSpring Health Services (BTSG) 10.0%).

Which stock has performed better?

Over the past year BrightSpring Health Services (BTSG) returned the most: Mckesson (MCK) +30.3%, Cvs Health (CVS) +12.7%, BrightSpring Health Services (BTSG) +124.3%. Over five years, Mckesson (MCK) compounded fastest (Mckesson (MCK) +37.5%/yr, Cvs Health (CVS) -1.0%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Cvs Health (CVS) has the highest dividend yield: Mckesson (MCK) 0.31%, Cvs Health (CVS) 2.99%. BrightSpring Health Services (BTSG) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Mckesson (MCK) has been the steadiest (Mckesson (MCK) 31.4%, Cvs Health (CVS) 35.1%, BrightSpring Health Services (BTSG) 45.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, MCK, CVS and BTSG?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mckesson (MCK) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.